Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.40
+0.03 (+2.19%)
Range 1.35 - 1.40
Open 1.39
Prev Close 1.37
52 Week 1.04 - 2.57
Volume 642950
Market Cap 720.7M
*Delayed 10/24/2014 3:59 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000